TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet

Clinical trial NCT00752310 · COMPLETED

Trial details

NCT number: NCT00752310
Sponsor: Tibotec Pharmaceuticals, Ireland
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2008-04-01
Primary completion: 2008-08-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.